Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Amortizatization of Intangibles (2020 - 2022)

Historic Amortizatization of Intangibles for Pharma (IGC) over the last 3 years, with Q3 2022 value amounting to $26000.0.

  • Pharma's Amortizatization of Intangibles changed 0.0% to $26000.0 in Q3 2022 from the same period last year, while for Sep 2022 it was $116000.0, marking a year-over-year increase of 10714.29%. This contributed to the annual value of $115000.0 for FY2022, which is 42272.73% up from last year.
  • Pharma's Amortizatization of Intangibles amounted to $26000.0 in Q3 2022, which was down 0.0% from $28000.0 recorded in Q2 2022.
  • Over the past 5 years, Pharma's Amortizatization of Intangibles peaked at $35000.0 during Q1 2022, and registered a low of -$2000.0 during Q3 2020.
  • Its 3-year average for Amortizatization of Intangibles is $19100.0, with a median of $26000.0 in 2021.
  • In the last 5 years, Pharma's Amortizatization of Intangibles soared by 260000.0% in 2021 and then changed by 0.0% in 2022.
  • Quarter analysis of 3 years shows Pharma's Amortizatization of Intangibles stood at $1000.0 in 2020, then soared by 2600.0% to $27000.0 in 2021, then fell by 3.7% to $26000.0 in 2022.
  • Its Amortizatization of Intangibles was $26000.0 in Q3 2022, compared to $28000.0 in Q2 2022 and $35000.0 in Q1 2022.